David Jin - Net Worth and Insider Trading
David Jin Net Worth
The estimated net worth of David Jin is at least $246,114 dollars as of 2026-09-10. David Jin is the CFO of Fortress Biotech Inc and owns about 93,522 shares of Fortress Biotech Inc (FBIO) stock worth over $245,963. David Jin is also the Director of Mustang Bio Inc and owns about 286 shares of Mustang Bio Inc (MBIO) stock worth over $151. Details can be seen in David Jin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Jin has not made any transactions after 2025-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Jin
David Jin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Jin owns 3 companies in total, including Avenue Therapeutics Inc (ATXI) , Fortress Biotech Inc (FBIO) , and Mustang Bio Inc (MBIO) .
Click here to see the complete history of David Jin’s form 4 insider trades.
Insider Ownership Summary of David Jin
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2022-05-11 | Int. PEO & Int. PFO & and COO |
| FBIO | Fortress Biotech Inc | 2022-11-30 | Chief Financial Officer |
| MBIO | Mustang Bio Inc | 2025-12-30 | director |
David Jin Latest Holdings Summary
David Jin currently owns a total of 2 stocks. Among these stocks, David Jin owns 93,522 shares of Fortress Biotech Inc (FBIO) as of November 30, 2022, with a value of $245,963 and a weighting of 99.94%. David Jin also owns 286 shares of Mustang Bio Inc (MBIO) as of December 30, 2025, with a value of $151 and a weighting of 0.06%.
Latest Holdings of David Jin
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FBIO | Fortress Biotech Inc | 2022-11-30 | 93,522 | 2.63 | 245,963 |
| MBIO | Mustang Bio Inc | 2025-12-30 | 286 | 0.53 | 151 |
Holding Weightings of David Jin
David Jin Form 4 Trading Tracker
According to the SEC Form 4 filings, David Jin has made a total of 1 transactions in Fortress Biotech Inc (FBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fortress Biotech Inc is the acquisition of 333 shares on November 30, 2022, which cost David Jin around $2,800.
According to the SEC Form 4 filings, David Jin has made a total of 1 transactions in Mustang Bio Inc (MBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mustang Bio Inc is the acquisition of 247 shares on December 30, 2025, which cost David Jin around $237.
Insider Trading History of David Jin
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
David Jin Trading Performance
GuruFocus tracks the stock performance after each of David Jin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Jin is -5.13%. GuruFocus also compares David Jin's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Jin within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Jin's insider trading performs compared to the benchmark.
David Jin Ownership Network
Ownership Network List of David Jin
Ownership Network Relation of David Jin

David Jin Owned Company Details
What does Avenue Therapeutics Inc do?
Who are the key executives at Avenue Therapeutics Inc?
David Jin is the Int. PEO & Int. PFO & and COO of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Robert L Davidow , 10 percent owner Fortress Biotech, Inc. , and 10 percent owner Invagen Pharmaceuticals, Inc. .
Avenue Therapeutics Inc (ATXI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avenue Therapeutics Inc (ATXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avenue Therapeutics Inc Insider Transactions
David Jin Mailing Address
Above is the net worth, insider trading, and ownership report for David Jin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David Jin's mailing address is: Waltham Ma 02453.